Cargando…

Comparison of the effects of weekly and biweekly intravenous CERA administration on erythropoiesis: A randomized controlled trial

Although continuous erythropoietin receptor activators (CERAs) are widely used erythropoiesis‐stimulating agents for correcting renal anemia in patients undergoing hemodialysis (HD), few reports have examined weekly CERA administration. In this randomized controlled trial, we compared the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawai, Yuki, Toya, Yoshiyuki, Wakui, Hiromichi, Fujikawa, Tetsuya, Ueda, Eiko, Azushima, Kengo, Mitsuhashi, Hiroshi, Kawano, Tomoyuki, Kuji, Tadashi, Yamaguchi, Satoshi, Ohnishi, Toshimasa, Tamura, Kouichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Erythropoietin
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678717/ https://www.ncbi.nlm.nih.gov/pubmed/33481341 http://dx.doi.org/10.1111/jch.14171

Ejemplares similares

Systematic review and meta-analysis for prevention of cardiovascular complications using GLP-1 receptor agonists and SGLT-2 inhibitors in obese diabetic patients
por: Uneda, Kazushi, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertension
por: Azushima, Kengo, et al.
Publicado: (2022)

Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients
por: Kanai, Daisuke, et al.
Publicado: (2022)

SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
por: Kanai, Daisuke, et al.
Publicado: (2022)

Bofu-Tsu-Shosan, an Oriental Herbal Medicine, Exerts a Combinatorial Favorable Metabolic Modulation Including Antihypertensive Effect on a Mouse Model of Human Metabolic Disorders with Visceral Obesity
por: Azushima, Kengo, et al.
Publicado: (2013)

Updates for Cardio‐Kidney Protective Effects by Angiotensin Receptor‐Neprilysin Inhibitor: Requirement for Additional Evidence of Kidney Protection
por: Tsukamoto, Shunichiro, et al.
Publicado: (2023)

Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis
por: Kanai, Daisuke, et al.
Publicado: (2023)

Addition of Aliskiren to Angiotensin Receptor Blocker Improves Ambulatory Blood Pressure Profile and Cardiorenal Function Better than Addition of Benazepril in Chronic Kidney Disease
por: Ohsawa, Masato, et al.
Publicado: (2013)

L/N-Type Calcium Channel Blocker Cilnidipine Added to Renin-Angiotensin Inhibition Improves Ambulatory Blood Pressure Profile and Suppresses Cardiac Hypertrophy in Hypertension with Chronic Kidney Disease
por: Kanaoka, Tomohiko, et al.
Publicado: (2013)

Effects of Single Pill-Based Combination Therapy of Amlodipine and Atorvastatin on Within-Visit Blood Pressure Variability and Parameters of Renal and Vascular Function in Hypertensive Patients with Chronic Kidney Disease
por: Azushima, Kengo, et al.
Publicado: (2014)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Adipocyte‐Specific Enhancement of Angiotensin II Type 1 Receptor‐Associated Protein Ameliorates Diet‐Induced Visceral Obesity and Insulin Resistance
por: Azushima, Kengo, et al.
Publicado: (2017)

Upstream Stimulatory Factors 1 and 2 Mediate the Transcription of Angiotensin II Binding and Inhibitory Protein
por: Matsuda, Miyuki, et al.
Publicado: (2013)

Angiotensin Receptor–Binding Protein ATRAP/Agtrap Inhibits Metabolic Dysfunction With Visceral Obesity
por: Maeda, Akinobu, et al.
Publicado: (2013)

Blood Pressure Elevation of Tubular Specific (P)RR Transgenic Mice and Lethal Tubular Degeneration due to Possible Intracellular Interactions between (P)RR and Alternative Renin Products
por: Saigo, Sae, et al.
Publicado: (2021)

Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
por: Tsukamoto, Shunichiro, et al.
Publicado: (2022)

ATRAP Expression in Brown Adipose Tissue Does Not Influence the Development of Diet-Induced Metabolic Disorders in Mice
por: Ohki, Kohji, et al.
Publicado: (2017)

Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis
por: Minegishi, Shintaro, et al.
Publicado: (2019)

Effects of ATRAP in Renal Proximal Tubules on Angiotensin‐Dependent Hypertension
por: Kinguchi, Sho, et al.
Publicado: (2019)

Angiotensin II type 1 receptor-associated protein deficiency attenuates sirtuin1 expression in an immortalised human renal proximal tubule cell line
por: Yamaji, Takahiro, et al.
Publicado: (2019)

Angiotensin II Type 1 Receptor‐Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin
por: Uneda, Kazushi, et al.
Publicado: (2017)

Persona di cera/
por: Tynianov, IU. N. 1894-1943 (IUrii Nikolaevich)

Eplerenone-Resistant Salt-Sensitive Hypertension in Nedd4-2 C2 KO Mice
por: Kino, Tabito, et al.
Publicado: (2017)

An Isoform of Nedd4-2 Plays a Pivotal Role in Electrophysiological Cardiac Abnormalities
por: Minegishi, Shintaro, et al.
Publicado: (2017)

Deletion of the angiotensin II type 1 receptor–associated protein enhances renal sodium reabsorption and exacerbates angiotensin II–mediated hypertension
por: Ohsawa, Masato, et al.
Publicado: (2014)

El museo de cera
por: Edwards, Jorge
Publicado: (1997)

El museo de cera
por: Edwards, Jorge
Publicado: (1981)

Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue
por: Ohki, Kohji, et al.
Publicado: (2018)

Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice
por: Azushima, Kengo, et al.
Publicado: (2019)

Effects of tumor necrosis factor-α inhibition on kidney fibrosis and inflammation in a mouse model of aristolochic acid nephropathy
por: Taguchi, Shinya, et al.
Publicado: (2021)

Effects of Rikkunshito treatment on renal fibrosis/inflammation and body weight reduction in a unilateral ureteral obstruction model in mice
por: Wakui, Hiromichi, et al.
Publicado: (2020)

Renal Tubule Angiotensin II Type 1 Receptor–Associated Protein Promotes Natriuresis and Inhibits Salt‐Sensitive Blood Pressure Elevation
por: Wakui, Hiromichi, et al.
Publicado: (2015)

Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
por: Uehara, Tatsuki, et al.
Publicado: (2023)

Museo de cera ; manual de exploradores, 1960-1972
por: Alvarez, José María, 1942-
Publicado: (1974)

Hombres con alas de cera /
por: Cruz Oliva, Oscar René
Publicado: (2003)

La cera en México : arte e historia
por: Esparza Liberal, María José
Publicado: (1994)

Author Correction: Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization
por: Abe, Eriko, et al.
Publicado: (2022)

Angiotensin II type-1 receptor-associated protein interacts with transferrin receptor-1 and promotes its internalization
por: Abe, Eriko, et al.
Publicado: (2022)

Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice
por: Urate, Shingo, et al.
Publicado: (2021)

Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease
por: Kinguchi, Sho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rs727qtjlh5em0tvtslq0ohssc